5-Bromo-2-ethyl-1H-pyrrolo[2,3-b]pyridine, 97%, 250mg

9,9-Dimethyl-9H-fluoren-2-ylboronic acid, 95.0%, 5g

N-(2,3-dihydro-1,4-benzodioxin-6-yl)guanidine, 95.0%, 500mg

(2-Bromo-3-(trifluoromethyl)phenyl)methanamine hydrochloride, 95.0%, 5g

Magnetic bar ejector ROTILABO®, 350 mm, 1 piece

2,6-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[1,2-b:4,5-b']dithiophene>97.0%(GC)1g

3-Bromobicyclo[1.1.1]pentane-1-carbonitrile, 97%, 250mg

(2E)-1-(4-Methylphenyl)-3-{4-[(1E)-3-(4-methylphenyl)-3-oxoprop-1-en-1-yl]phenyl}prop-2-en-1-one, tech, 1g

(S)-Octan-2-ol, 95.0%, 100g

2-Chloro-4-methylquinoline, 95.0%, 1g

(4-(3-(Trifluoromethyl)-3H-diazirin-3-yl)phenyl)methanol, 95%, 250mg

2-(3-(3-Methoxyphenyl)allylidene)malonic acid, 95.0%, 5g

1-Ethynyladamantane, 95.0%, 25g